Stock PTGX PROTAGONIST THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Protagonist Therapeutics, Inc.

Equities

PTGX

US74366E1029

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-04-29 EDT 		5-day change 1st Jan Change
25.56 USD +1.63% Intraday chart for Protagonist Therapeutics, Inc. -3.95% +11.47%
04-03 Protagonist Therapeutics Insider Sold Shares Worth $707,750, According to a Recent SEC Filing MT
03-26 Protagonist Therapeutics, Inc. Provides Update on Verify Patient Enrollment and Timing of Top-Line Data CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
PROTAGONIST THERAPEUTICS, INC. Stock Protagonist Therapeutics, Inc.
 1.5B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 42.86B
LONZA GROUP AG Stock Lonza Group AG
 41.36B
MODERNA, INC. Stock Moderna, Inc.
 42.74B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.68B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 25.15B
  1. Stock Market
  2. Equities
  3. PTGX Stock
  4. Charts Protagonist Therapeutics, Inc.
  5. Sector Chart